Pueraria mirifica clinical study in Premenopausal women

Medicinal Plant Research Institute, Department of Medical Sciences, Ministry of Public Health, Thailand; July 2000

Clinical Study : Premenopausal Women

Product type : Pueraria mirifica Premium Grade

Function : Health Food (Food Supplement)

Test Period : 2 months

Number of Testers :

31 Placebo

32 consumer 400 mg/day, 15 days/month

34 consumer 800 mg/day, 15 days/month

The results are summarized in following details as in below;

The placebo group contains 31 testers, had received tapioca starch filled capsule to consume 2 capsules/day for 15 days/month started from the first day of the menstruation period, for 2 consecutive months. This group showed no significance change in all record parameters.

The first tested group contains 32 testers, had received 200 mg @ 2 capsules each per day of Pueraria mirifica filled capsule in the same condition as the placebo group.

This group showed significance change with different number in all recorded parameters, including mammary pain (44%) which is related to Breast firmness and may relate also to breast enlargement, skin recovering (88%), healthier hair (75%), charisma clearance (100%), increase vaginal secretion (44%), healthier menstruation (6%), breast firmness (44%), breast enlargement (9%), and hip enlargement (9%)

The second tested group contains 34 testers, had received 200 mg @ 4 capsules – Pueraria mirifica filled capsule to consume 4 capsules/day in the same condition as the placebo group.

Conclusion

In conclusion, the human test as a food supplement or functional food product has shown its estrogenic effects clearly among testers, including skin reformed, hair complexity, breast firmness, and possible to induce breast enlargement.

Pueraria mirifica studies

Thai biologist claims tuber can enlarge bust size

Pueraria mirifica decreases breast tumor incidence

Efficacy comparison of Pueraria mirifica (PM) against conjugated equine estrogen (CEE) with/without medroxyprogesterone acetate (MPA) in the treatment of climacteric symptoms in perimenopausal women: phase III study

Pueraria mirifica reduce Breast cancer risks

Research and Study on Pueraria mirifica

A national – level committee is set up to push for export – processing.

The effect of Pueraria mirifica on cytologic and urodynamic findings in ovariectomized rats.Effects and safety of Pueraria mirifica on lipid profiles and biochemical markers of bone turnover rates in healthy postmenopausal women.

Effects and safety of Pueraria mirifica on lipid profiles and biochemical markers of bone turnover rates in healthy postmenopausal women.

Long-term treatment effects of Pueraria mirifica phytoestrogens on parathyroid hormone and calcium levels in aged menopausal cynomolgus monkeys.

Pueraria mirifica, a phytoestrogen-rich herb, prevents bone loss in orchidectomized rats.

Finished herbal product as an alternative treatment for menopausal symptoms in climacteric women.